
New Drug Development for Transplantation and GvHD Using SLY-1 Inhibitor

The invention relates to a pharmaceutical composition comprising an inhibitor of SLY-1 (SH3 domain protein expressed in lymphocytes).
Further Information: PDF
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000
Contact
Dr. Wolfgang Knappe